Using low-dose aspirin after preeclampsia to improve recovery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot trial aims to evaluate the feasibility and effects of low-dose aspirin on vascular recovery in postpartum individuals who have experienced preeclampsia. Participants will be randomly assigned to receive either 81mg of low-dose aspirin or a placebo daily for six months after delivery. The study will involve monitoring blood pressure, conducting blood draws, and assessing endothelial function through microiontophoresis at multiple visits. The goal is to determine if aspirin can improve endothelial function and lower blood pressure in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Postpartum individuals ≥18 years old
* Preeclampsia diagnosis

Exclusion Criteria:

* Fetal anomaly
* Multiple gestation
* Pre-pregnancy hypertension
* Allergy or contraindication to low-dose aspirin
* Pre-pregnancy diabetes

Where it's running

• University of Pittsburgh Magee-Womens Hospital
  Pittsburgh, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Alisse K Hauspurg, MD — UPMC Magee Women's Hospital
• Study coordinator: Alisse K Hauspurg, MD
• Email: janickia@upmc.edu
• Phone: 412-641-1381

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preeclampsia Biomarker Test in African Women

  This study tests whether measuring the sFlt-1/PlGF ratio using quick clinic tests helps predict which pregnant women in Africa will develop severe preeclampsia.

  Recruiting Africa Clinical Research Network (ACRN) · Harare, Harare · NCT07810439

• Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy

  This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.

  Recruiting Phase 4 Alexandra Hospital, Athens, Greece · Athens, Attica · NCT07361679

• Pre-eclampsia risk in pregnancies after oocyte donation

  We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.

  Recruiting at 6 sites Copenhagen University Hospital, Hvidovre · Copenhagen and 5 other locations · NCT07263490

• RADIANCE CED: long-term outcomes after ultrasound renal denervation

  This project will see if ultrasound renal denervation (using the Paradise system) lowers blood pressure over the long term in Medicare-age adults (65+) with uncontrolled hypertension by using their medical records.

  Recruiting at 2 sites ReCor Medical, Inc. · Detroit, Michigan and 1 other locations · NCT07231757

• Postpartum high blood pressure: trying enalapril after delivery

  This study tests whether giving enalapril after delivery can help postpartum women with hypertensive disorders of pregnancy manage blood pressure.

  Recruiting Phase 3 Women and Infants Hospital of Rhode Island · Providence, Rhode Island · NCT07222852

• Pulmonary Artery Denervation for a specific type of heart and lung pressure problem

  This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.

  Recruiting at 18 sites Pulnovo Medical, Inc. · Tucson, Arizona and 18 other locations · NCT07214376

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.